150mg Erlocip Erlotinib Tablets

150mg Erlocip Erlotinib Tablets Specification

Life Span
24 months from the date of manufacture

Indication
Treatment of advanced or metastatic non-small cell lung cancer and pancreatic cancer

Packaging Type
Box

Dosage Form
Oral solid tablet

Brand Name
Erlocip 150

Salt Composition
Erlotinib Hydrochloride 150mg

Pacakaging (Quantity Per Box)
30 Tablets

Origin of Medicine
India

Drug Type
Prescription Medicine

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablet

Function
Anticancer / Antineoplastic agent

Recommended For
Non-Small Cell Lung Cancer; Pancreatic Cancer

Dosage
As prescribed by the physician

Dosage Guidelines
Take at least one hour before or two hours after meals

Suitable For
Adults

Quantity
30 Tablets per box

Storage Instructions
Store below 30C; protect from moisture and light

Tablet Shape
Oval

HSN Code
30049099

Side Effects
Rash, diarrhea, loss of appetite, fatigue, and nausea

Precautions
Monitor liver and kidney function during therapy

Colour
White to Off-White

Route of Administration
Oral

Marketed By
Cipla Ltd.

Strength
150mg

Prescription/Non Prescription
Prescription

Warning
Not recommended during pregnancy and breastfeeding

150mg Erlocip Erlotinib Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About 150mg Erlocip Erlotinib Tablets

Strength	150mg
Form	Tablet
Pack Size	1*30 Tablet
Pack Type	Box
Treatment	Treats non small cell lung cancer
Brand	Erlocip
Manufacturer	Cipla
Composition	Erlotinib

Erlotinib is an epidermal growth factor receptor/human epidermal growth factor receptor type 1 (EGFR, also known as HER1) tyrosine kinase inhibitor. Erlotinib potently inhibits the intracellular phosphorylation of EGFR. EGFR is expressed on the cell surface of normal cells and cancer cells.

Targeted Therapy for Cancer

Erlocip 150 targets specific pathways involved in cancer cell growth, offering a tailored treatment option for non-small cell lung cancer and pancreatic cancer. Its antineoplastic action helps slow the progression of advanced cancers, aiming for improved patient outcomes when used under medical supervision.

Guidelines for Use and Storage

This medication must be taken orally, exactly as prescribed, ensuring a gap from meals for optimal absorption. Patients should maintain regular check-ups for liver and kidney function. Erlocip 150 should be stored at temperatures below 30C, away from moisture and direct light, preserving its efficacy throughout its 24-month shelf life.

Safety and Precautionary Measures

Pregnancy and breastfeeding should be avoided while taking Erlocip 150. Common side effects include rash, diarrhea, loss of appetite, fatigue, and nausea. Close monitoring and prompt reporting of adverse effects to the prescribing physician are recommended to ensure safe therapy.

FAQ's of 150mg Erlocip Erlotinib Tablets:

Q: How does Erlocip 150mg work in cancer treatment?

A: Erlocip 150mg (Erlotinib) inhibits specific proteins involved in the growth and spread of cancer cells, particularly targeting receptors active in non-small cell lung and pancreatic cancers. This action helps slow disease progression and may improve treatment effectiveness.

Q: What is the correct way to take Erlocip 150mg tablets?

A: Take Erlocip 150mg orally as prescribed by your physician, making sure to do so at least one hour before or two hours after meals. Follow the prescribed dosage and timing strictly to enhance the medicine's absorption and effectiveness.

Q: When should I consult my doctor during Erlocip 150mg therapy?

A: Regular consultations are essential, especially for periodic monitoring of your liver and kidney functions. Contact your physician immediately if you experience severe side effects such as persistent rash, diarrhea, or unusual fatigue.

Q: Where should I store Erlocip 150mg tablets?

A: Store Erlocip 150mg tablets in their original packaging at temperatures below 30C, protected from moisture and direct light, to maintain their stability and potency.

Q: What are the potential side effects of Erlocip 150mg?

A: Common side effects include skin rash, diarrhea, nausea, loss of appetite, and fatigue. If any of these symptoms become severe or concerning, notify your doctor promptly.

Q: What precautions should I take while using Erlocip 150mg?

A: Avoid using this medication if pregnant or breastfeeding. Regular monitoring of liver and kidney function is advised throughout your treatment course. Adhere strictly to your doctor's instructions regarding dosage and administration.

Q: What are the main benefits of choosing Erlocip 150mg for cancer treatment?

A: Erlocip 150mg offers a targeted treatment for advanced non-small cell lung and pancreatic cancers, aiming to hinder cancer cell proliferation. Its oral tablet form ensures convenience for adults under medical supervision.